Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.43 |
| ▸ | LPL | P06858 | 8/20 | 0.43 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | PRKDC | P78527 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24217342 | 0.92 | ALOX5 (0.48) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL22135386 | 0.92 | ALOX5 (0.50) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL22760814 | 0.92 | ALOX5 (0.50) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL25073616 | 0.91 | LIPG (0.54) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL20259765 | 0.90 | LIPG (0.49) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL22738106 | 0.88 | ALOX5 (0.47) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL22737993 | 0.87 | ALOX5 (0.50) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL18090451 | 0.87 | LIPG (0.49) | ALOX5LIPGLPLCSF1RPRKDC | |
| SCHEMBL21756013 | 0.86 | LIPG (0.43) | ALOX5LIPGLPLCSF1RPRMT5 | |
| SCHEMBL21756116 | 0.85 | LIPG (0.50) | LIPGLPLCSF1RPRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389344-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230389344-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20220389018-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2022-12-08 | — | — | US | disclosed |
| US-20210280800-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
| WO-2020040571-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389018-A1 | ORGANIC LIGHT EMITTING DEVICE | CYP1A1, ARNT, AOC3 | ALOX5 1861/4885LIPG 3975/4885LPL 2528/4885 |
| US-20210280800-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, AOX1, CYBA | ALOX5 497/4885LIPG 1731/4885LPL 1573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.